Aeterna Zentaris
AEZS
#10800
Rank
โ‚ฌ15.6 M
Marketcap
5,10ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2023 (TTM): -4,39ย โ‚ฌ

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -1,83ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,16ย โ‚ฌ a decrease over its 2021 EPS that were of -1,75ย โ‚ฌ.

EPS history for Aeterna Zentaris from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,39ย โ‚ฌ5.46%
2022-4,16ย โ‚ฌ138.27%
2021-1,75ย โ‚ฌ-48.05%
2020-3,36ย โ‚ฌ-56.88%
2019-7,80ย โ‚ฌ-240%
20185,57ย โ‚ฌ-122.94%
2017-24,28ย โ‚ฌ-54.96%
2016-53,91ย โ‚ฌ-93.07%
2015-777,69ย โ‚ฌ20.13%
2014-647,38ย โ‚ฌ-225.69%
2013515,06ย โ‚ฌ-122.24%
2012-2.316ย โ‚ฌ-42.55%
2011-4.032ย โ‚ฌ-12.98%
2010-4.634ย โ‚ฌ-17.46%
2009-5.614ย โ‚ฌ-62.5%
2008-14.970ย โ‚ฌ83.66%
2007-8.151ย โ‚ฌ-227.16%
20066.410ย โ‚ฌ105.81%
20053.115ย โ‚ฌ-334.56%
2004-1.328ย โ‚ฌ-79.94%
2003-6.620ย โ‚ฌ13.5%
2002-5.833ย โ‚ฌ604.55%
2001-827,92ย โ‚ฌ-84.33%
2000-5.285ย โ‚ฌ296.86%
1999-1.332ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,68ย โ‚ฌ-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1,70ย โ‚ฌ-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
4,03ย โ‚ฌ-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,32ย โ‚ฌ-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
3,14ย โ‚ฌ-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA